Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |